Combination of 4‐hydroperoxy cyclophosphamide and methotrexate inhibits IL‐6/sIL‐6R‐induced RANKL expression in fibroblast‐like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway